BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

GNOMvsPBEETF Comparison

ETF 1

GNOM

Global X Genomics & Biotechnology ETF

This fund is part of

BioTech & Genomics

+0.29%

Full GNOM fund page

VS

ETF 2

PBE

Invesco Dynamic Biotechnology & Genome ETF

This fund is part of

BioTech & Genomics

+0.29%

Full PBE fund page

Global X Genomics & Biotechnology ETF (GNOM) and Invesco Dynamic Biotechnology & Genome ETF (PBE) belong to the same industry segment: BioTech & Genomics. In contrast, PBE's top sector exposures are Healthcare. GNOM is less expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.59% for PBE. GNOM is up 36.95% year-to-date (YTD) with +$21M in YTD flows. PBE performs worse with 14.29% YTD performance, and +$114M in YTD flows. Run a side-by-side ETF comparison of GNOM and PBE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

GNOM vs PBE performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 09/11/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	GNOM PBE	+4.57%-1.08%	+27.28%+10.60%	+36.95%+14.29%	+69.95%+32.37%	+43.87%+57.10%	-32.85%+25.03%
Flows	GNOM PBE	+$2M+$36M	+$18M+$117M	+$21M+$114M	+$15M+$113M	-$54M+$62M	-$42M+$64M

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	GNOM PBE	+37.85%+19.34%	+30.56%+19.23%	+30.36%+20.46%	+33.83%+22.56%
Max drawdown	GNOM PBE	-8.57%-5.97%	-18.16%-11.70%	-43.10%-22.21%	-71.04%-33.32%
Max drawdown duration	GNOM PBE	32d8d	145d166d	674d324d	1818d1509d

Trading data

Create an account to view trading data

Join for free

	GNOM	PBE
Last sale 9/14/2026 at 1:30 PM	$63.57	$93.64
Previous close 09/11/2026	$62.22	$92.91
Consolidated volume 09/11/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of August 31, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free

	GNOM	PBE
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 9/14/2026 at 1:30 PM

Live

Closed

	GNOM	PBE
Last price	$63.57	$93.64
1D performance	+2.17%	+0.79%
AuM	$93.74 M	$404.80 M
E/R	0.5%	0.59%

Characteristics

	GNOM	PBE
Management strategy	Passive	Passive
Provider	Global X	Invesco
Benchmark	Solactive Genomics Index	Dynamic Biotech & Genome Intellidex Index
N° of holdings	-	30
Asset class	Equities	Equities
Trailing 12m distribution yield	Join	Join
Inception date	April 5, 2019	June 23, 2005
ESG	No	No

More GNOM data on Trackinsight

More PBE data on Trackinsight

Exposure

Countries

GNOM

Data will be available soon

PBE

USA

97.13%

Other

2.87%

Sectors

GNOM

Data will be available soon

PBE

Healthcare

100%

Other

0%

Diversification

GNOM

Data will be available soon

PBE

Total weight of top 15 holdings out of 15

61.32%

Top 15 holdings

Data as of January 1, 1970

GNOM

Data will be available soon

PBE

Amgen, Inc.

5.16%

Vertex Pharmaceuticals, Inc.

4.96%

Royalty Pharma Plc

4.91%

Regeneron Pharmaceuticals, Inc.

4.90%

Biogen, Inc.

4.85%

Gilead Sciences, Inc.

4.44%

Alnylam Pharmaceuticals, Inc.

4.34%

United Therapeutics Corp.

4.06%

CareDx, Inc.

4.01%

Bio-Techne Corp.

3.66%

Illumina, Inc.

3.27%

Vericel Corp.

3.25%

Protagonist Therapeutics, Inc.

3.24%

Incyte Corp.

3.19%

Veracyte, Inc.

3.07%

Frequently asked questions about GNOM and PBE

GNOMvsPBEETF Comparison

Global X Genomics & Biotechnology ETF

Invesco Dynamic Biotechnology & Genome ETF

GNOM vs PBE performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the GNOM and PBE ETFs performed in 2026?

As of September 11, 2026, GNOM is up 36.95% year-to-date (YTD), while PBE has returned 14.29%. That puts GNOM better performer ahead so far this year.

Which ETF is attracting more investor money: GNOM or PBE?

Year-to-date, the GNOM ETF saw +$21M in flows, compared to +$114M for PBE.

Which ETF is more volatile: GNOM or PBE?

Over the past year, GNOM had a volatility of 30.56%, while PBE experienced 19.23%.

Which ETF is bigger: GNOM or PBE?

As of September 11, 2026, GNOM holds $93.74 M in assets under management (AUM), while PBE manages $404.80 M.

Build and Analyze Your ETF Portfolio Like a Pro